DRD3 and melanoma: Our findings provide evidence indicating that a genetic deficiency of DRD3 impairs the production of IL-2 by CD8+ T-cells, which is associated with attenuated expansion and acquisition of effector function by these cells, and with reduced efficacy of the anti-tumour response in a melanoma mouse model.